Forums and Workshop (September 12) - ET (Eastern Time, GMT-05:00)
The workshop will outline key processes for mastering intellectual property diligence in biotechnology transactions, to enable attendees to master intellectual property diligence in biotechnology transactions. Key topics and current trends that arise in venture capital investment rounds, securities offerings, licensing of assets, and other transactions will be covered.
- Chad Davis - Partner, Dechert LLP
Join our exclusive, invite only, Medtech BD Leaders Forum—an unparalleled gathering of 10-12 top-tier BD leaders.
Our forum will include an open format giving opportunity for general group discussions, featuring case studies, which foster candid and open dialogue about industry trends, deal structuring, valuation, approaches to partnering and more, with your peers.
Come and connect with like-minded professionals, forge strategic alliances, and expand your professional network.
General Discussion (suggested topics to include but not limited to);
- Hearing from BD leaders in attendance on how their companies are structured
- Interaction with corporate BD vs. corporate M&A
- Dedicated investment funds vs non dedicated funds? What are the drawbacks?
- Insight on deal timelines (from getting a deal started to fruition)
- Real life transaction insights/ examples (no proprietary info)
- Approaches to partnering
- Experience working with startups (opportunities & challenges)
Our forum operates under 🔒 Chatham House Rule: Promoting a free-flowing exchange of ideas, the Chatham House Rule ensures a confidential and productive environment, encouraging open and honest discussions.